Answers are grounded in this paper and cite their sources.
For cancer precision medicine, designing optimization method for identifying critical biomarkers is essential for early clinical intervention. However, existing optimization methods rely on static network analysis, ignoring the temporal dynamics of gene interaction networks and lacking effective integration of biological prior knowledge during the optimization process, leading to limited performance. To address these issues, this paper proposes a novel prior knowledge embedded dynamic multi-objective optimization algorithm termed TRDMO-P for disease critical biomarker identification. Our TRDMO-P algorithm fully exploits temporal dynamics of gene interaction network with two core strategies, i.e., prior biological gene-guided population initialization for effective optimization search and faster convergence, as well as network topology degree-guided evolution to retain effective biological genes and ensure biologically consistent optimization. Experiments on The Cancer Genome Atlas cancer datasets, and esophageal single-cell transcriptome data demonstrate that TRDMO-P significantly improves the detection accuracy of early warning signals compared with state-of-the-art methods, and ablation studies validate the effectiveness of the two proposed strategies, indicating that the proposed method enables reliable and biologically meaningful identification of critical biomarkers and shows strong potential for applications in cancer precision medicine.
No takes yet. Share an insight, caveat, or question.
Cheng et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: